Non-Alcoholic fatty liver disease (NAFLD) and Cardiovascular Risk: Is Imaging helpful?
Current problems in cardiology
NAFLD; cardiovascular; imaging
NAFLD is proving to be a globally prevalent condition and is on the rise. Moreover, NAFLD might be an independent risk factor associated with higher CVD morbidity and mortality. More studies need to assess whether NAFLD needs to be included in the atherosclerotic risk score algorithms or whether patients with NAFLD need to be screened early on to assess their CVD risk especially since imaging such as positron emission tomography can be used to assess both NAFLD and CV disease at the same time. Hence, employing cardiovascular imaging modalities to investigate the incidence, extent and nature of atherosclerotic lesions In NAFLD may be beneficial. Additionally, whether treating NAFLD halts the progression of CAD on imaging remains to be seen. Further research to delineate NAFLD and CVD associations, deciphering screening imaging modalities and investigating targeted interventions could improve CVD morbidity and mortality in NAFLD.
Doumas, Stavros A.; Tripathi, Shalini; Kashikar, Aditi; Khuttan, Akhilesh; Kumar, Ashwin; Singh, Harjit; Canakis, Justin P.; Ashish, Kumar; Dey, Debashish; Oppenheim, Ian; and Dey, Amit Kumar, "Non-Alcoholic fatty liver disease (NAFLD) and Cardiovascular Risk: Is Imaging helpful?" (2023). GW Authored Works. Paper 3196.
School of Medicine and Health Sciences Resident Works